Reproductive goals change the risk-benefit equation entirely. When Weight Loss Is Not the Right Primary Goal Not everyone who wants a GLP-1 medication benefits from weight loss as the first intervention
Cost considerations without insurance (as of 2025): Wegovy (semaglutide): approximately $1,300-$1,500 per month Saxenda (liraglutide): approximately $1,300-$1,400 per month Zepbound (tirzepatide): approximately $1,000-$1,200 per month These prices reflect list prices
Insomnia or Restlessness: Some individuals may experience difficulty sleeping (insomnia) or feelings of restlessness after receiving MIC+B12 injections, particularly if they are sensitive to the effects of Vitamin B12
About OASIS 4 OASIS 4 was a 64-week phase 3 randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of once-daily oral semaglutide 25 mg versus placebo in 307 adults with obesity (BMI 30 kg/m 2 ) or overweight (BMI 27 kg/m 2 ) with one or more weight-related comorbidities